checkAd
    Startseite > Aktien > Decibel Therapeutics > Nachrichten
    Decibel Therapeutics Aktie
    4,9100
     
    USD
    0,00 %
    0,0000 USD
    Letzter Kurs 23.09.23 Nasdaq
    4,9300
     
    USD
    5.100 STK
    Geldkurs 22.09.23
    4,9500
     
    USD
    100 STK
    Briefkurs 22.09.23
    ISIN: US24343R1068 · WKN: A2QNAQ · SYM: DBTX · USA

    Neueste Nachrichten

    DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX
    05.09.23 · Business Wire (engl.) · Decibel Therapeutics
    DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX
    12.08.23 · Business Wire (engl.) · Decibel Therapeutics
    Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update
    11.08.23 · globenewswire · Decibel Therapeutics
    DBTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Decibel Therapeutics, Inc. Is Fair to Shareholders
    09.08.23 · Business Wire (engl.) · Decibel Therapeutics
    Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference
    02.06.23 · globenewswire · Decibel Therapeutics
    Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
    01.06.23 · globenewswire · Decibel Therapeutics
    Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit
    17.05.23 · globenewswire · Decibel Therapeutics
    Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
    15.05.23 · globenewswire · Decibel Therapeutics
    Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO
    12.05.23 · globenewswire · Decibel Therapeutics
    Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
    10.05.23 · globenewswire · Decibel Therapeutics